232 related articles for article (PubMed ID: 19509224)
1. Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma.
Yang ZZ; Novak AJ; Ziesmer SC; Witzig TE; Ansell SM
Cancer Res; 2009 Jul; 69(13):5522-30. PubMed ID: 19509224
[TBL] [Abstract][Full Text] [Related]
2. CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells.
Yang ZZ; Novak AJ; Ziesmer SC; Witzig TE; Ansell SM
Blood; 2007 Oct; 110(7):2537-44. PubMed ID: 17615291
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma.
Yang ZZ; Novak AJ; Stenson MJ; Witzig TE; Ansell SM
Blood; 2006 May; 107(9):3639-46. PubMed ID: 16403912
[TBL] [Abstract][Full Text] [Related]
4. Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
Gergely L; Aleksza M; Váróczy L; Ponyi A; Sipka S; Illés A; Szegedi G
Eur J Haematol; 2004 May; 72(5):336-41. PubMed ID: 15059068
[TBL] [Abstract][Full Text] [Related]
5. TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin's lymphoma.
Yang ZZ; Grote DM; Xiu B; Ziesmer SC; Price-Troska TL; Hodge LS; Yates DM; Novak AJ; Ansell SM
Leukemia; 2014 Sep; 28(9):1872-84. PubMed ID: 24569779
[TBL] [Abstract][Full Text] [Related]
6. Soluble and membrane-bound TGF-β-mediated regulation of intratumoral T cell differentiation and function in B-cell non-Hodgkin lymphoma.
Yang ZZ; Grote DM; Ziesmer SC; Xiu B; Yates NR; Secreto FJ; Hodge LS; Witzig TE; Novak AJ; Ansell SM
PLoS One; 2013; 8(3):e59456. PubMed ID: 23555036
[TBL] [Abstract][Full Text] [Related]
7. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.
Kristensen B
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836805
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas.
Chaperot L; Delfau-Larue MH; Jacob MC; Molens JP; Roussel B; Agrawal S; Farcet JP; Gressin R; Sotto JJ; Bensa JC; Plumas J
Exp Hematol; 1999 Jul; 27(7):1185-93. PubMed ID: 10390194
[TBL] [Abstract][Full Text] [Related]
9. A B-cell lymphoma vaccine using a depot formulation of interleukin-2 induces potent antitumor immunity despite increased numbers of intratumoral regulatory T cells.
Grille S; Brugnini A; Nese M; Corley E; Falkenberg FW; Lens D; Chabalgoity JA
Cancer Immunol Immunother; 2010 Apr; 59(4):519-27. PubMed ID: 19768458
[TBL] [Abstract][Full Text] [Related]
10. IL-9 contributes to immunosuppression mediated by regulatory T cells and mast cells in B-cell non-hodgkin's lymphoma.
Feng LL; Gao JM; Li PP; Wang X
J Clin Immunol; 2011 Dec; 31(6):1084-94. PubMed ID: 21898141
[TBL] [Abstract][Full Text] [Related]
11. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
Chaperot L; Plumas J; Jacob MC; Bost F; Molens JP; Sotto JJ; Bensa JC
Exp Hematol; 1999 Mar; 27(3):479-88. PubMed ID: 10089910
[TBL] [Abstract][Full Text] [Related]
12. Identification of IL-17-producing FOXP3+ regulatory T cells in humans.
Voo KS; Wang YH; Santori FR; Boggiano C; Wang YH; Arima K; Bover L; Hanabuchi S; Khalili J; Marinova E; Zheng B; Littman DR; Liu YJ
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4793-8. PubMed ID: 19273860
[TBL] [Abstract][Full Text] [Related]
13. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
[TBL] [Abstract][Full Text] [Related]
14. Human regulatory T cells suppress proliferation of B lymphoma cells.
Grygorowicz MA; Biernacka M; Bujko M; Nowak E; Rymkiewicz G; Paszkiewicz-Kozik E; Borycka IS; Bystydzienski Z; Walewski J; Markowicz S
Leuk Lymphoma; 2016 Aug; 57(8):1903-20. PubMed ID: 26758248
[TBL] [Abstract][Full Text] [Related]
15. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.
Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH
Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma.
Yang ZZ; Novak AJ; Ziesmer SC; Witzig TE; Ansell SM
Cancer Res; 2006 Oct; 66(20):10145-52. PubMed ID: 17047079
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
[TBL] [Abstract][Full Text] [Related]
18. Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes.
Kasprzycka M; Zhang Q; Witkiewicz A; Marzec M; Potoczek M; Liu X; Wang HY; Milone M; Basu S; Mauger J; Choi JK; Abrams JT; Hou JS; Rook AH; Vonderheid E; Woetmann A; Odum N; Wasik MA
J Immunol; 2008 Aug; 181(4):2506-12. PubMed ID: 18684941
[TBL] [Abstract][Full Text] [Related]
19. Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones.
Umetsu DT; Esserman L; Donlon TA; DeKruyff RH; Levy R
J Immunol; 1990 Apr; 144(7):2550-7. PubMed ID: 1969451
[TBL] [Abstract][Full Text] [Related]
20. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
